The measurements used to define pulmonary hypertension (PH) etiology, pulmonary arterial wedge pressure (PAWP), and left ventricular end-diastolic pressure (LVEDP) vary in clinical practice. We aimed to identify clinical features associated with measurement discrepancy between PAWP and LVEDP in patients with PH.
Distinguishing precapillary and postcapillary pulmonary hypertension (PH) requires invasive hemodynamic measurements. It is important to accurately diagnose these conditions because their underlying pathophysiology and clinical management differ markedly. [1] [2] [3] In clinical practice, left ventricular end-diastolic pressure (LVEDP) and pulmonary arterial wedge pressure (PAWP) are used as surrogates for left atrial pressure. Many clinicians rely solely on PAWP obtained during right heart catheterization (RHC) because measurement of LVEDP requires an additional procedure with arterial access. 2, 3 PAWP closely approximates LVEDP in many cases, but recent literature has suggested that overreliance on this metric may misclassify PH etiology. [4] [5] [6] In a large referral cohort, Halpern and Taichman  7 found that nearly 50% of patients are misclassified using PAWP alone, but no demographic or clinical data were reported to help identify individuals at risk of misclassification. Mascherbauer et al 8 recently
reported that low diffusion capacity of carbon monoxide is a determinant of PAWP/LVEDP discordance in patients with heart failure. Other studies examining discordance between PAWP and LVEDP have been limited by small sample sizes and/or homogeneous populations. 4, 5 Little is known about patient characteristics in which LVEDP and PAWP are discordant in an unselected referral population. A better understanding of these characteristics is important because it may help identify patients at risk of PH misclassification and provide guidance on which patients may benefit from measurement of LVEDP in addition to PAWP.
We sought to determine the frequency and predictors of PAWP and LVEDP discordance in a richly phenotyped cohort of unselected patients referred for simultaneous RHC and left heart catheterization (LHC).
Methods

Study Population
This study was approved by the Vanderbilt University institutional review board (No. 140544). Data for this retrospective cohort study were extracted from Vanderbilt's Synthetic Derivative database, a deidentified version of Vanderbilt's electronic medical record originating in 1995. The design and implementation of the Synthetic Derivative have been previously described, 9, 10 and findings from this cohort have been previously reported. [11] [12] [13] During the deidentification process, protected health information is removed and dates are randomly shifted up to AE 365 days while remaining internally consistent for a given patient.
Hemodynamic Data and Group Definitions
We queried the Synthetic Derivative for all patients who underwent simultaneous RHC and LHC between 1998 (when digital catheterization reports became available) and 2014. A unique algorithm using regular expressions and pattern matching was developed to extract structured, quantitative data from all catheterization reports. For this study, if a patient had multiple catheterizations or provocative testing, only resting data from the first procedure were analyzed. Inpatients and outpatients were included in this study, but patients with values suggestive of acute decompensation (eg, shock, vital signs suggesting imminent death) or cardiac-related critical illness (eg, hypertensive crisis) were excluded, as previously described. 12 These patients were excluded because the intent of this study was to examine the relationship between wedge pressure and LVEDP in a more controlled setting (not during extreme critical illness) to identify predictable scenarios in which they differ. Nonphysiologic data suggestive of entry error (eg, arterial saturation > 100%, negative cardiac output) were deleted, and missing or deleted data were imputed for regression analyses (see Statistical Analysis for details). No PAWP, LVEDP, or mean pulmonary arterial pressure values were imputed.
Patients were categorized according to contemporary guidelines by the hemodynamic values on the RHC and LHC reports. 1 PH was defined as a mean pulmonary arterial pressure $ 25 mm Hg. Precapillary and postcapillary PH were defined as mean pulmonary arterial pressure $ 25 mm Hg and divided into concordant (LVEDP and PAWP agree) and discordant (LVEDP and PAWP disagree) around a threshold of 15 mm Hg. Values for this study represent the computer-generated mean, which we have shown to have strong agreement with manual review in our catheterization laboratory. 12 
Clinical and Outcome Data
Demographic and hemodynamic data were obtained on the date of RHC. Hemodynamic variables were extracted from the catheterization report. The thermodilution method was used when cardiac output and index were reported with both Fick and thermodilution methods. Comorbidity, echocardiographic, and laboratory data were restricted to 6 months before or after RHC, and the temporally closest values were used. We defined comorbidities based on International Classification of Diseases, Ninth Revision coding or validated algorithms, as previously reported. 11, 12, 14 We extracted laboratory values that reflect disease severity (brain natriuretic peptide) or comorbid conditions (glomerular filtration rate, hemoglobin A1c).
Statistical Analyses
Data are expressed as median, 25th percentile, and 75th percentile for continuous variables and absolute value and percentages for categorical variables, unless stated otherwise. PAWP and LVEDP relationships were assessed by scatterplot, linear prediction plot, and BlandAltman analysis. To identify invalid data, we used histograms and cross-referenced published cohorts to evaluate outliers, 15 removing values thought to be nonphysiologic. To minimize the bias associated with missing data, we imputed 20 datasets for all regression analyses using multiple imputation with additive regression, bootstrapping, and predictive mean matching. 16 The variance-covariance matrix for parameter estimates was adjusted for the variability introduced by myocardial infarction. Multiple logistic regression was used to identify covariates associated with PAWP and LVEDP discordance around the threshold of 15 mm Hg. Models included only patients with hemodynamic PH for whom discrepancies between PAWP and LVEDP were most clinically meaningful. To avoid overfitting the model, we selected 10 demographic, clinical, laboratory, and hemodynamic covariates a priori. Results are reported as ORs with 95% CI and P values. We performed additional sensitivity analyses including restricting our cohort to (1) patients with PAWP or LVEDP between 13 and 17 mm Hg to identify sources of large error, which is more informative clinically; and (2) patients with pulmonary vascular resistance > 3 Wood units. Models for sensitivity analyses included fewer variables to avoid overfitting. Variables for sensitivity analyses were selected based on clinical knowledge and performance in the primary analysis. Statistical analysis was performed using R (R version 3.3.1; R Foundation) and Stata for Macintosh (Version 14.0; StataCorp).
Results
Cohort Characteristics
Among 5,797 unique patients referred for RHC, we excluded 585 individuals for incomplete data and 861 patients for prespecified exclusion criteria (Fig 1) . Of the remaining 4,351 individuals, 2,270 were referred for RHC and LHC and had complete hemodynamic data, constituting our final cohort. The median age of the cohort was 63 years (interquartile range [IQR], 53-71), and 53% were men and 85% were white (Table 1 ). There was a high prevalence of medical comorbidities, particularly cardiovascular disease, and 42% of the cohort was obese. The most common indications for RHC (e- Table 1 ) were coronary artery disease (38%), valvular heart disease (18%), and congestive heart failure (16%). Compared with patients referred for RHC only, those referred for both RHC and LHC were older and had a higher prevalence of cardiopulmonary comorbidities (e- Table 2 ).
Agreement and Correlation of PAWP and LVEDP
Among the 2,270 patients with both measurements, the mean difference between PAWP minus LVEDP was À1.6 mm Hg (IQR, À15 to 12 mm Hg); however, the range was wide (À18 to 30 mm Hg) (Fig 2A) . The two measurements were moderately correlated by linear regression (R 2 ¼ 0.36, P < .001) (Fig 2B) . 
Sensitivity Analysis
Modest discrepancies between PAWP and LVEDP may not be clinically meaningful. Therefore, in sensitivity 
Discussion
The objective of this study was to identify clinical features associated with PH misclassification arising from discrepancy between the PAWP and the gold standard surrogate, LVEDP. Although PAWP/LVEDP discrepancies are well described, patient characteristics associated with PAWP/LVEDP disagreement have not been examined in large, well-phenotyped cohorts. The mean disagreement between PAWP and LVEDP was modest in our cohort (1.6 mm Hg); however, the range of disagreement was wide and misclassification of PH etiology would have occurred in nearly 30% of patients if RHC alone were performed. Importantly, features associated with misclassification of precapillary or postcapillary PH were consistent when subjects with values near 15 mm Hg and low pulmonary vascular resistance were excluded. Older age was associated with wedge underestimation of LVEDP, whereas wedge overestimation of LVEDP was more likely to be observed in patients with atrial fibrillation, a diagnosis of rheumatic valve disease, and larger left atrial diameter. These findings are important to patients and their Lower diffusion capacity of carbon monoxide was associated with a higher gradient using stepwise multivariate linear regression. This study highlights a group at risk of PAWP/LVEDP discrepancy; however, pulmonary function parameters are not available in many patients referred for catheterization. These studies bring important awareness to clinically meaningful measurement discrepancies but are limited by lack of rich demographic and clinical information to ascertain which patients are at risk of PH misclassification. 4, 5, 7 Although discrepancies may be attributable in part to unique physiologic mechanisms (eg, atrial fibrillation), human error also likely contributes. We observed that PAWP and LVEDP differed by at least 20% in nearly two-thirds of our cohort, which is difficult to blame solely on physiology. These measurements require meticulous attention to waveforms, timing, and zeroing practices, among other considerations. We were unable to assess variability in discrepant measurements across operators, but this is an important consideration for future studies and in the interpretation of hemodynamic data in clinical practice.
We identified several important associations that may assist clinicians in the decision of whether or not to refer for concurrent LVEDP measurement. Older age was associated with PAWP underestimation of LVEDP in our primary analysis, but did not remain significant when borderline values were excluded. The mechanism for how PAWP underestimates LVEDP with increasing age is unclear, but the observation is consistent with the current understanding of PH epidemiology and our prior report that group II PH is the predominant PH phenotype in older adults. 17 In our cohort, atrial fibrillation and presence of an International Classification of Diseases, Ninth Revision code for rheumatic valvular disease were consistently associated with higher PAWP than LVEDP. These observations may reflect a true difference between left atrial and left ventricular diastolic pressures based on the unique physiology of these conditions. In rheumatic mitral valve disease, atrial and ventricular pressures are dissociated because of a stenotic valve, but elevated left atrium pressure is transmitted to the pulmonary vasculature.
Our data confirm prior studies reporting that PAWP is often higher than LVEDP in patients with atrial fibrillation at the time of RHC. 18, 19 These results reflect the physiology of atrial fibrillation (reduced atrial compliance and impaired transport function) but are also strongly influenced by measurement technique. [20] [21] [22] [23] Our dataset reports computer-generated mean pressures, which are averaged over the cardiac cycle and therefore include contributions of the v wave. This may elevate PAWP compared with LVEDP, which is an end-diastolic measure only. The relative contribution of the v wave to the computer-generated mean pressure is exaggerated in atrial fibrillation because the a wave is absent. 24 Our study confirms the importance of recognizing this phenomenon in clinical practice because 31% of our cohort had a diagnosis of atrial fibrillation.
As pointed out by others, the clinical utility of PAWP and LVEDP depends on the clinical scenario and the question being asked. 21, 23 The observation that PAWP overestimates LVEDP as left atrial diameter increases reflects adverse atrial remodeling in response to chronically elevated left ventricular filling pressure. This also raises the notion that PAWP better reflects pressure transmitted to the pulmonary circulation and is likely the more informative measurement when assessing the symptomatic patient. Recent data from Mascherbauer et al 8 support this notion by showing that PAWP is more strongly associated with outcomes in patients with chestjournal.org heart failure. Further studies are warranted examining the prognostic associations of PAWP and LVEDP in a larger, unselected population.
We did not observe expected PAWP/LVEDP discrepancies in subjects with COPD or interstitial lung disease, which may lead to intrapleural pressure changes that dissociate PAWP and LVEDP. 25, 26 A potential explanation-in addition to a true finding-is that our dataset uses the computer-generated mean for PAWP and LVEDP measurements. We did observe, in both primary and sensitivity analyses, that higher BMI was associated with PAWP overestimation of LVEDP. A potential mechanism for this observation is that obesity increases pleural pressure, 26 which may compress the thin-walled atrium (increasing pressure), but not the thicker left ventricle; however, this is speculation.
These data should be interpreted in the context of several limitations. Vanderbilt University is a referral center for both complex cardiovascular disease and pulmonary vascular disease, making these conditions overrepresented in our cohort compared with the general population. Our PAWP and LVEDP measurements were extracted directly from the medical record, not through manual review of hemodynamic tracings. In prior work, we have demonstrated generally good correlation between manual reading and computer interpretations within this electronic medical recordbased cohort. 12 We examined only clinical data that are routinely available in patients referred for RHC, including echocardiographic parameters of cardiac structure and function. It is likely that additional end points, including pulmonary function test parameters, would have provided additional insight, but those data were not available in our cohort.
Conclusions
This study identified clinical scenarios in which clinicians should consider the addition of LVEDP measurement to standard RHC measurements in patients at risk of PH. These findings are important because of the fundamental differences in the pathophysiology and treatment of preand postcapillary PH.
